Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial von Powles, Thomas, Kockx, Mark, Rodriguez-Vida, Alejo, Duran, Ignacio, Crabb, Simon J., Van Der Heijden, Michiel S., Szabados, Bernadett, Pous, Albert Font, Gravis, Gwenaelle, Herranz, Urbano Anido, Protheroe, Andrew, Ravaud, Alain, Maillet, Denis, Mendez, Maria Jose, Suarez, Cristina, Linch, Mark, Prendergast, Aaron, van Dam, Pieter-Jan, Stanoeva, Diana, Daelemans, Sofie, Mariathasan, Sanjeev, Tea, Joy S., Mousa, Kelly, Banchereau, Romain, Castellano, Daniel

Volltext

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer von Powles, Thomas, Valderrama, Begoña P., Gupta, Shilpa, Bedke, Jens, Kikuchi, Eiji, Hoffman-Censits, Jean, Iyer, Gopa, Vulsteke, Christof, Park, Se Hoon, Shin, Sang Joon, Castellano, Daniel, Fornarini, Giuseppe, Li, Jian-Ri, Gümüş, Mahmut, Mar, Nataliya, Loriot, Yohann, Fléchon, Aude, Duran, Ignacio, Drakaki, Alexandra, Narayanan, Sujata, Yu, Xuesong, Gorla, Seema, Homet Moreno, Blanca, van der Heijden, Michiel S.

Volltext

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma von van der Heijden, Michiel S., Sonpavde, Guru, Powles, Thomas, Necchi, Andrea, Burotto, Mauricio, Schenker, Michael, Sade, Juan Pablo, Bamias, Aristotelis, Beuzeboc, Philippe, Bedke, Jens, Oldenburg, Jan, Chatta, Gurkamal, Ürün, Yüksel, Ye, Dingwei, He, Zhisong, Valderrama, Begoña P., Ku, Ja Hyeon, Tomita, Yoshihiko, Filian, Jeiry, Wang, Lily, Purcea, Daniela, Patel, Miraj Y., Nasroulah, Federico, Galsky, Matthew D.

Volltext

The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact von van Dessel, Lisanne F., van Riet, Job, Smits, Minke, Zhu, Yanyun, Hamberg, Paul, van der Heijden, Michiel S., Bergman, Andries M., van Oort, Inge M., de Wit, Ronald, Voest, Emile E., Steeghs, Neeltje, Yamaguchi, Takafumi N., Livingstone, Julie, Boutros, Paul C., Martens, John W. M., Sleijfer, Stefan, Cuppen, Edwin, Zwart, Wilbert, van de Werken, Harmen J. G., Mehra, Niven, Lolkema, Martijn P.

Volltext

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer von Patel, K. M., van der Vos, K. E., Smith, C. G., Mouliere, F., Tsui, D., Morris, J., Chandrananda, D., Marass, F., van den Broek, D., Neal, D. E., Gnanapragasam, V. J., Forshew, T., van Rhijn, B. W., Massie, C. E., Rosenfeld, N., van der Heijden, M. S.

Volltext

Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune‐related adverse events of immune checkpoint inhibitors von Lin, Lishi, Houwink, Aletta P. I., van Dieren, Jolanda M., Wolthuis, Esther K., van Thienen, Johannes V., van der Heijden, Michiel S., Haanen, John B. A. G., Beijnen, Jos H., Huitema, Alwin D. R.

Volltext

A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer von Palit, Sander A. L., van Dorp, Jeroen, Vis, Daniel, Lieftink, Cor, Linder, Simon, Beijersbergen, Roderick, Bergman, Andries M., Zwart, Wilbert, van der Heijden, Michiel S.

Volltext

Impact of smoking behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study - CORRIGENDUM von van der Heijden, Heleen S, Schirmbeck, Frederike, Kempton, Matthew J, van der Gaag, Mark, Allott, Kelly, Nelson, Barnaby, Ruhrmann, Stephan, de Haan, Lieuwe, Vermeulen, Jentien M

Volltext

The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer von van Dijk, Nick, Gil-Jimenez, Alberto, Silina, Karina, van Montfoort, Maurits L, Einerhand, Sarah, Jonkman, Lars, Voskuilen, Charlotte S, Peters, Dennis, Sanders, Joyce, Lubeck, Yoni, Broeks, Annegien, Hooijberg, Erik, Vis, Daniel J, van den Broek, Maries, Wessels, Lodewyk F A, van Rhijn, Bas W G, van der Heijden, Michiel S

Volltext

Impact of smoking behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study von van der Heijden, Heleen S., Schirmbeck, Frederike, Kempton, Matthew J., van der Gaag, Mark, Allott, Kelly, Nelson, Barnaby, Ruhrmann, Stephan, de Haan, Lieuwe, Vermeulen, Jentien M

Volltext

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised c... von Powles, Thomas, Durán, Ignacio, van der Heijden, Michiel S, Loriot, Yohann, Vogelzang, Nicholas J, De Giorgi, Ugo, Oudard, Stéphane, Retz, Margitta M, Castellano, Daniel, Bamias, Aristotelis, Fléchon, Aude, Gravis, Gwenaëlle, Hussain, Syed, Takano, Toshimi, Leng, Ning, Kadel, Edward E, Banchereau, Romain, Hegde, Priti S, Mariathasan, Sanjeev, Cui, Na, Shen, Xiaodong, Derleth, Christina L, Green, Marjorie C, Ravaud, Alain

Volltext

The relationship between substance use and self-reported aspects of social functioning in patients with a psychotic disorder von van der Heijden, H S, Kikkert, Martijn, de Haan, Lieuwe, Segeren, Menno, Molman, Simone, Schirmbeck, Frederike, Vermeulen, Jentien

Volltext

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial von Bellmunt, Joaquim, Hussain, Maha, Gschwend, Jürgen E, Albers, Peter, Oudard, Stephane, Castellano, Daniel, Daneshmand, Siamak, Nishiyama, Hiroyuki, Majchrowicz, Martin, Degaonkar, Viraj, Shi, Yi, Mariathasan, Sanjeev, Grivas, Petros, Drakaki, Alexandra, O'Donnell, Peter H, Rosenberg, Jonathan E, Geynisman, Daniel M, Petrylak, Daniel P, Hoffman-Censits, Jean, Bedke, Jens, Kalebasty, Arash Rezazadeh, Zakharia, Yousef, van der Heijden, Michiel S, Sternberg, Cora N, Davarpanah, Nicole N, Powles, Thomas

Volltext

Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial von Yu, Evan Y, Petrylak, Daniel P, O'Donnell, Peter H, Lee, Jae-Lyun, van der Heijden, Michiel S, Loriot, Yohann, Stein, Mark N, Necchi, Andrea, Kojima, Takahiro, Harrison, Michael R, Hoon Park, Se, Quinn, David I, Heath, Elisabeth I, Rosenberg, Jonathan E, Steinberg, Joyce, Liang, Shang-Ying, Trowbridge, Janet, Campbell, Mary, McGregor, Bradley, Balar, Arjun V

Volltext

TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth von Palit, Sander Al, Vis, Daniel, Stelloo, Suzan, Lieftink, Cor, Prekovic, Stefan, Bekers, Elise, Hofland, Ingrid, Šuštić, Tonći, Wolters, Liesanne, Beijersbergen, Roderick, Bergman, Andries M, Győrffy, Balázs, Wessels, Lodewyk Fa, Zwart, Wilbert, van der Heijden, Michiel S

Volltext

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial von Balar, Arjun V, Dr, Galsky, Matthew D, MD, Rosenberg, Jonathan E, MD, Powles, Thomas, MD, Petrylak, Daniel P, MD, Bellmunt, Joaquim, MD, Loriot, Yohann, MD, Necchi, Andrea, MD, Hoffman-Censits, Jean, MD, Perez-Gracia, Jose Luis, MD, Dawson, Nancy A, MD, van der Heijden, Michiel S, MD, Dreicer, Robert, MD, Srinivas, Sandy, MD, Retz, Margitta M, MD, Joseph, Richard W, MD, Drakaki, Alexandra, MD, Vaishampayan, Ulka N, MD, Sridhar, Srikala S, MD, Quinn, David I, MD, Durán, Ignacio, MD, Shaffer, David R, MD, Eigl, Bernhard J, MD, Grivas, Petros D, MD, Yu, Evan Y, MD, Li, Shi, PhD, Kadel, Edward E, BS, Boyd, Zachary, MSc, Bourgon, Richard, PhD, Hegde, Priti S, PhD, Mariathasan, Sanjeev, PhD, Thåström, AnnChristine, PhD, Abidoye, Oyewale O, MD, Fine, Gregg D, MD, Bajorin, Dean F, MD

Volltext

The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer von van Dijk, Nick, Funt, Samuel A., Blank, Christian U., Powles, Thomas, Rosenberg, Jonathan E., van der Heijden, Michiel S.

Volltext

Response Rate to Chemotherapy After Immune Checkpoint Inhibition in Metastatic Urothelial Cancer von Szabados, Bernadett, van Dijk, Nick, Tang, Yen Zhi, van der Heijden, Michiel S., Wimalasingham, Akhila, Gomez de Liano, Alfonso, Chowdhury, Simon, Hughes, Simon, Rudman, Sarah, Linch, Mark, Powles, Thomas

Volltext

Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancer von Mertens, Laura S, van der Heijden, Michiel S

Volltext

High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade von Yuen, Kobe C., Liu, Li-Fen, Gupta, Vinita, Madireddi, Shravan, Keerthivasan, Shilpa, Li, Congfen, Rishipathak, Deepali, Williams, Patrick, Kadel, Edward E., Koeppen, Hartmut, Chen, Ying-Jiun, Modrusan, Zora, Grogan, Jane L., Banchereau, Romain, Leng, Ning, Thastrom, AnnChristine, Shen, Xiadong, Hashimoto, Kenji, Tayama, Darren, van der Heijden, Michiel S., Rosenberg, Jonathan E., McDermott, David F., Powles, Thomas, Hegde, Priti S., Huseni, Mahrukh A., Mariathasan, Sanjeev

Volltext